Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLV/PPBT stock hub

TLV/PPBT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/PPBTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

18.6M

Tel Aviv Stock Exchange

Market data

Price

Recent price action with selectable time range.

TLV/PPBTTLV/PPBT

—

Loading chart…

In the news

Latest news · TLV/PPBT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-124.5

P25 n/aP50 n/aP75 n/a

ROIC-20.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/PPBT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

USD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	10
Employees Change	1%
Employees Change Percent	11.11
Enterprise value	ILA -11.3M
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	IL0007650166
Last refreshed	2026-05-10
Market cap	ILA 18.6M
Price	ILA 1
Price currency	ILA
Sector	Healthcare
Sic	2834
Symbol	tlv/PPBT
Website	https://purple-biotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-452.52%
EV Earnings	0.13x
EV/FCF	0.63x
FCF yield	-97.05%
P/B ratio	0.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	ILA -188,092
Net Income	ILA -84.1M
Net Income Growth Years	0%
Profit Per Employee	ILA -8.4M
ROA	-15.97
Roa5y	-19.58
ROCE	-71.05
ROE	-124.5
Roe5y	-51.72
ROIC	-20.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-53.58%
Cagr1y	-77.8%
Cagr3y	-76.66%
Cagr5y	-62.23%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	ILA 56M
Cash	ILA 30.5M
Current Assets	ILA 28.6M
Current Liabilities	ILA 22.5M
Debt	ILA 777,872
Debt Equity	ILA 0.03
Debt FCF	ILA -0.04
Equity	ILA 30.8M
Liabilities	ILA 25.2M
Long Term Assets	ILA 27.4M
Long Term Liabilities	ILA 2.7M
Net Cash	ILA 29.7M
Net Cash By Market Cap	ILA 160
Net Cash Growth	11.86%
Net Debt Equity	ILA -0.97
Tangible Book Value	ILA 7.5M
Tangible Book Value Per Share	ILA 0
WACC	1.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Net Working Capital	ILA -23M
Quick ratio	1.23
Working Capital	ILA 6.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-192.79%
Dividend per share	ILA 0
Last Dividend	ILA 0.96

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.95%
1Y total return	-77.78%
200-day SMA	1.98
3Y total return	-98.73%
50-day SMA	1.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.23%
All Time High	74,880
All Time High Change	-100%
All Time High Date	2013-10-08
All Time Low	1
All Time Low Change	0%
All Time Low Date	2025-09-09
ATR	0.01
Beta	-0.57
Beta1y	0.21
Beta2y	-0.19
Ch YTD	-16.67
High	1
High52	5.7
High52 Date	2025-07-24
High52ch	-82.46%
Low	1
Low52	1
Low52 Date	2026-05-07
Low52ch	0%
Ma50ch	-1.77%
Price vs 200-day SMA	-49.47%
RSI	40.99
RSI Monthly	30.11
RSI Weekly	0
Sharpe ratio	-1.28x
Sortino ratio	-1.66
Total Return	-192.79%
Tr YTD	-16.67

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -22.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,848,489,113%
Net Borrowing	-629,517
Shares Insiders	0.56%
Shares Institutions	19.63%
Shares Out	1,858,911,800
Shares Qo Q	161.42%
Shares Yo Y	192.79%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA -19M
Average Volume	532,416.25x
Bv Per Share	0.02
CAPEX	ILA -9,564
Ch10y	-99.95
Ch1y	-77.78
Ch3y	-98.73
Ch5y	-99.23
Ch6m	-16.67
Change	0%
Change From Open	0
Close	1
Days Gap	0
Depreciation Amortization	8,703
Dollar Volume	50,000
Earnings Date	2026-05-15
EBIT	ILA -22.2M
EBITDA	ILA -22.2M
EPS	ILA -0.09
F Score	1
FCF	ILA -18M
FCF EV Yield	159.23x
FCF Per Share	ILA -0.01
Financing CF	20,189,604
Fiscal Year End	December
Founded	1,968
Investing CF	2,014,816
Is Primary Listing	1
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Last Split Date	2019-01-06
Last Split Type	Reverse
Ma150	1.29
Ma150ch	-22.18%
Ma20	1
Ma20ch	0%
Net CF	4,195,408
Next Earnings Date	2026-05-15
Open	1
Ppne	1,003,746
Price Date	2026-05-07
Ptbv Ratio	2.48
Relative Volume	0.09x
Share Based Comp	985,092
Tr6m	-16.67%
Volume	50,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/PPBT pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/PPBT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/PPBT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.6%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+192.8%

Negative means the company is buying back shares.

Technical

TLV/PPBT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.0

Neutral momentum band

Price vs 200-day MA

-49.5%

50/200-day relationship not available

Beta (5Y)

-0.57

Less volatile than the market

Sharpe ratio

-1.28

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/PPBT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/PPBT stock rating?

tlv/PPBT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/PPBT analysis?

The full report lives at /stocks/tlv/PPBT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/PPBT?

The latest report frames tlv/PPBT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/PPBT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.